Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A KEITH

Showing results (731-740 of 918) with videos related to

Pageof 92
Sort By:
Physical Review Letters|October 15, 2016
Preparation of Entangled States through Hilbert Space EngineeringY Lin, J P Gaebler, F Reiter, et al.
Ejhaem|May 12, 2025
A Single-Center Study on Frontline Treatment for Multiple Myeloma Patients With 1q AbnormalitiesAshish Patel, Esther Masih-Khan, Adam Smith, et al.
Trends in Ecology & Evolution|March 13, 2016
A Trait-Based Approach to Advance Coral Reef ScienceJoshua S Madin, Mia O Hoogenboom, Sean R Connolly, et al.
Blood Cancer Journal|February 12, 2019
Identification of lenalidomide resistance pathways in myeloma and targeted resensitization using cereblon replacement, inhibition of STAT3 or targeting of IRF4Yuan Xiao Zhu, Chang-Xin Shi, Laura A Bruins, et al.
Molecular Ecology Resources|August 19, 2011
Gene transcription in sea otters (Enhydra lutris); development of a diagnostic tool for sea otter and ecosystem healthLizabeth Bowen, A Keith Miles, Michael Murray, et al.
Bioinformatics (Oxford, England)|August 18, 2004
DisProt: a database of protein disorderSlobodan Vucetic, Zoran Obradovic, Vladimir Vacic, et al.
Blood|August 30, 2002
A molecular compendium of genes expressed in multiple myelomaJaime O Claudio, Esther Masih-Khan, Hongchang Tang, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 9, 2012
An open-label single-arm pilot phase II study (PX-171-003-A0) of low-dose, single-agent carfilzomib in patients with relapsed and refractory multiple myelomaSundar Jagannath, Ravi Vij, A Keith Stewart, et al.
The Journal of Clinical Investigation|April 24, 2008
Identification of kinetin riboside as a repressor of CCND1 and CCND2 with preclinical antimyeloma activityRodger E Tiedemann, Xinliang Mao, Chang-Xin Shi, et al.
European Journal of Haematology|January 15, 2026
Survival and Renal Recovery in Newly Diagnosed Multiple Myeloma Patients Presenting With Dialysis-Requiring Severe Renal ImpairmentRintu Sharma, Eshetu G Atenafu, Esther Masih-Khan, et al.
Pageof 92

Showing results (731-740 of 918) with videos related to

Sort By:
Pageof 92
Physical Review Letters|October 15, 2016
Preparation of Entangled States through Hilbert Space EngineeringY Lin, J P Gaebler, F Reiter, et al.
Ejhaem|May 12, 2025
A Single-Center Study on Frontline Treatment for Multiple Myeloma Patients With 1q AbnormalitiesAshish Patel, Esther Masih-Khan, Adam Smith, et al.
Trends in Ecology & Evolution|March 13, 2016
A Trait-Based Approach to Advance Coral Reef ScienceJoshua S Madin, Mia O Hoogenboom, Sean R Connolly, et al.
Blood Cancer Journal|February 12, 2019
Identification of lenalidomide resistance pathways in myeloma and targeted resensitization using cereblon replacement, inhibition of STAT3 or targeting of IRF4Yuan Xiao Zhu, Chang-Xin Shi, Laura A Bruins, et al.
Molecular Ecology Resources|August 19, 2011
Gene transcription in sea otters (Enhydra lutris); development of a diagnostic tool for sea otter and ecosystem healthLizabeth Bowen, A Keith Miles, Michael Murray, et al.
Bioinformatics (Oxford, England)|August 18, 2004
DisProt: a database of protein disorderSlobodan Vucetic, Zoran Obradovic, Vladimir Vacic, et al.
Blood|August 30, 2002
A molecular compendium of genes expressed in multiple myelomaJaime O Claudio, Esther Masih-Khan, Hongchang Tang, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 9, 2012
An open-label single-arm pilot phase II study (PX-171-003-A0) of low-dose, single-agent carfilzomib in patients with relapsed and refractory multiple myelomaSundar Jagannath, Ravi Vij, A Keith Stewart, et al.
The Journal of Clinical Investigation|April 24, 2008
Identification of kinetin riboside as a repressor of CCND1 and CCND2 with preclinical antimyeloma activityRodger E Tiedemann, Xinliang Mao, Chang-Xin Shi, et al.
European Journal of Haematology|January 15, 2026
Survival and Renal Recovery in Newly Diagnosed Multiple Myeloma Patients Presenting With Dialysis-Requiring Severe Renal ImpairmentRintu Sharma, Eshetu G Atenafu, Esther Masih-Khan, et al.
Pageof 92